Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.57519 | 59 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.40506 | 56 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.4067 | 56 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.31923 | 55 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.29154 | 54 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.52045 | 56 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.54219 | 57 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.33591 | 54 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.33285 | 54 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.59082 | 60 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.38835 | 56 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.3485 | 55 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.40371 | 55 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.39588 | 56 |